K. Detjen
发表
B. Wiedenmann,
M. Schirner,
T. Plath,
2000,
The Journal of Cell Biology.
B. Wiedenmann,
M. Schirner,
T. Plath,
2000,
The Journal of Cell Biology.
J. Schulzke,
M. Fromm,
K. Detjen,
1999,
Journal of cell science.
J. Schulzke,
M. Fromm,
K. Detjen,
1998
.
U. Luecking,
G. Siemeister,
K. Detjen,
2006,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
B. Wiedenmann,
K. Detjen,
M. Pavel,
2013,
Endocrine-related cancer.
B. Wiedenmann,
G. Siemeister,
K. Detjen,
2008,
Gut.
R. Plummer,
J. Graham,
B. Wiedenmann,
2008,
European journal of cancer.
B. Wiedenmann,
T. Plath,
K. Detjen,
2002,
Journal of the National Cancer Institute.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2001,
Gut.
B. Nicke,
K. Detjen,
C. Logsdon,
1999,
The Journal of Biological Chemistry.
J. Schrader,
A. Grossman,
Samantha Exner,
2017,
PloS one.
J. Cervós-Navarro,
H. Haller,
K. Detjen,
1994,
Gastroenterology.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2003
.
B. Wiedenmann,
M. Schirner,
T. Plath,
2000,
The Journal of cell biology.
K. Detjen,
C. Logsdon,
M. Tseng,
1995,
The Journal of Biological Chemistry.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2003,
International journal of cancer.
B. Wiedenmann,
K. Thierauch,
K. Detjen,
2011,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
B. Wiedenmann,
K. Detjen,
M. Pavel,
2012
.
J. Chao,
K. Detjen,
S. Rosewicz,
1991,
Endocrinology.
I. Steffen,
V. Prasad,
K. Detjen,
2017,
Neuroendocrinology.
I. Steffen,
V. Prasad,
K. Detjen,
2017
.
F. Brembeck,
H. Buhr,
K. Detjen,
1998,
British Journal of Cancer.
K. Detjen,
S. Rosewicz,
Z. von Marschall,
2004,
Neuroendocrinology.
A. Dąbrowski,
K. Detjen,
C. Logsdon,
1997,
Digestion.
K. Detjen,
C. Logsdon,
J. Yang,
1995,
Proceedings of the National Academy of Sciences of the United States of America.
CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells.
K. Detjen,
C. Logsdon,
M. Tseng,
1997,
The American journal of physiology.
CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells.
K. Detjen,
C. Logsdon,
John A. Williams,
1997,
American journal of physiology. Cell physiology.
K. Detjen,
C. Logsdon,
M. Tseng,
1995
.
K. Detjen,
S. Rosewicz,
Z. von Marschall,
2004,
Neuroendocrinology.
K. Detjen,
M. Welzel,
H. Gabius,
2011,
Cell Death and Differentiation.
Janne Lehtiö,
Hanna Eriksson,
Maho Amano,
2012,
The FEBS journal.
J. Schulzke,
M. Fromm,
K. Detjen,
2006,
Annals of the New York Academy of Sciences.
Jane Y. Wu,
B. Wiedenmann,
K. Detjen,
2014,
Cancer research.
U. Leser,
B. Wiedenmann,
C. Sers,
2023,
Cancers.
B. Wiedenmann,
K. Detjen,
A. Rabien,
2012,
Cancer science.
U. Leser,
D. Lenze,
N. Blüthgen,
2022,
Genome medicine.
U. Leser,
D. Lenze,
N. Blüthgen,
2020,
bioRxiv.
M. Trippel,
T. Grob,
B. Wiedenmann,
2022,
bioRxiv.
F. Tacke,
B. Wiedenmann,
K. Detjen,
2020,
Neuroendocrinology.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2001
.
F. Brembeck,
B. Wiedenmann,
K. Detjen,
2000,
Gastroenterology.
B. Wiedenmann,
M. Schirner,
K. Detjen,
2008,
British Journal of Cancer.
T. Sakai,
B. Wiedenmann,
L. Khachigian,
2005,
Journal of Biological Chemistry.
C. Schmitt,
B. Wiedenmann,
K. Detjen,
2010,
PloS one.
C. Schmitt,
B. Wiedenmann,
K. Detjen,
2010
.
K. Detjen,
C. Logsdon,
M. Fenrich,
1997,
Gastroenterology.
B. Wiedenmann,
M. Schirner,
K. Detjen,
2003,
Gastroenterology.
M. Pacyna‐Gengelbach,
U. Leser,
D. Lenze,
2020
.
B. Wiedenmann,
K. Detjen,
B. Schlegelberger,
2011,
British Journal of Cancer.
Christian Fischer,
K. Detjen,
M. Welzel,
2010,
The FEBS journal.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2001,
Hepatology.
U. Leser,
F. Tacke,
B. Wiedenmann,
2021,
Cancers.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2003,
Experimental cell research.
P. Schlag,
K. Detjen,
W. Kemmner,
2012,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
H. Brenner,
J. Chang-Claude,
M. Hoffmeister,
2019,
International journal of cancer.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2008,
Cancer research.
Peter Hauff,
Sonja Vollmer,
Bertram Wiedenmann,
2010,
Clinical Cancer Research.
F. Brembeck,
B. Wiedenmann,
H. Haller,
2000,
Journal of cell science.
A. Drost,
B. Wiedenmann,
K. Detjen,
2002
.
Interferon-gamma inhibits growth of human neuroendocrine carcinoma cells via induction of apoptosis.
A. Drost,
B. Wiedenmann,
K. Detjen,
2002,
International Journal of Oncology.
F. Brembeck,
H. Buhr,
K. Detjen,
1998
.
Jane Y. Wu,
B. Wiedenmann,
K. Detjen,
2014,
Cancer research.
B. Wiedenmann,
K. Detjen,
M. Welzel,
2008,
Cancer research.